{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:58:03Z","timestamp":1792166283891,"version":"4.4.0"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2017-0187_s_999_w2aab3b7c37b1b6b1aab1c16b1Aa\">\n                  <jats:title>Aim:<\/jats:title>\n                  <jats:p>Preterm birth is the world\u2019s leading cause of neonatal death. Unfortunately, the pathophysiology of preterm birth remains poorly understood. Sj\u00f6gren-Larsson syndrome is a rare, neurometabolic disorder caused by a fatty aldehyde dehydrogenase deficiency. A majority of patients with Sj\u00f6gren-Larsson syndrome is born preterm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0187_s_998_w2aab3b7c37b1b6b1aab1c16b2Aa\">\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Data of all known Dutch patients with Sj\u00f6gren-Larsson syndrome and all cases reported in literature were analyzed to learn from preterm birth in context of this rare disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0187_s_997_w2aab3b7c37b1b6b1aab1c16b3Aa\">\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Exact gestational age was known in 33 Dutch patients; 24 (73%) of them were born preterm, with a median gestational age of 36 weeks. The literature search confirmed our findings: 13 (59%) of 22 cases was born preterm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2017-0187_s_996_w2aab3b7c37b1b6b1aab1c16b4Aa\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Preterm birth is a hallmark of Sj\u00f6gren-Larsson syndrome, presumably caused by the abnormal lipid metabolism of the fetus. At least five additional rare genetic disorders (namely Ehlers-Danlos syndrome, ichthyosis prematurity syndrome, congenital analbuminemia, osteogenesis imperfecta type II and restrictive dermopathy) were found in literature that lead to preterm birth of the affected fetus. These disorders are in fact \u201cexperiments of nature\u201d and as such they shed new lights on the mechanisms causing preterm birth.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2017-0187","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T10:01:57Z","timestamp":1505469717000},"page":"523-529","source":"Crossref","is-referenced-by-count":10,"title":["Understanding fetal factors that contribute to preterm birth: Sj\u00f6gren-Larsson syndrome as a model"],"prefix":"10.1515","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-1412","authenticated-orcid":false,"given":"Pippa","family":"Staps","sequence":"first","affiliation":[{"name":"Department of Pediatric Neurology , Radboud University Medical Center, Donders Institute for Brain Cognition and Behaviour , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"Hogeveen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Radboud University Medical Center, Amalia Children\u2019s Hospital , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Fuijkschot","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Radboud University Medical Center, Amalia Children\u2019s Hospital , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"van Drongelen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics , Radboud University Medical Center , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8l A.A.P.","family":"Willemsen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology , Radboud University Medical Center, Donders Institute for Brain Cognition and Behaviour , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,9,15]]},"reference":[{"key":"2025021114263399713_j_jpm-2017-0187_ref_001_w2aab3b7c37b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162\u201372.","DOI":"10.1016\/S0140-6736(12)60820-4"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_002_w2aab3b7c37b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Monangi NK, Brockway HM, House M, Zhang G, Muglia LJ. The genetics of preterm birth: progress and promise. Semin Perinatol. 2015;39:574\u201383.","DOI":"10.1053\/j.semperi.2015.09.005"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_003_w2aab3b7c37b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760\u20135.","DOI":"10.1126\/science.1251816"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_004_w2aab3b7c37b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN. Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Hum Reprod Update. 2016;22:535\u201360.","DOI":"10.1093\/humupd\/dmw022"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_005_w2aab3b7c37b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010;362:529\u201335.","DOI":"10.1056\/NEJMra0904308"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_006_w2aab3b7c37b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Smith R. Parturition. N Engl J Med. 2007;356:271\u201383.","DOI":"10.1056\/NEJMra061360"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_007_w2aab3b7c37b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Elovitz MA, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol. 2000;183:674\u201381.","DOI":"10.1067\/mob.2000.106751"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_008_w2aab3b7c37b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. Br J Obstet Gynaecol. 2006;113(Suppl 3):17\u201342.","DOI":"10.1111\/j.1471-0528.2006.01120.x"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_009_w2aab3b7c37b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Adams Waldorf KM, Singh N, Mohan AR, Young RC, Ngo L, Das A, et al. Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates. Am J Obstet Gynecol. 2015;213:830 e1\u2013e19.","DOI":"10.1016\/j.ajog.2015.08.028"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_010_w2aab3b7c37b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Willemsen MA, IJlst L, Steijlen PM, Rotteveel JJ, de Jong JG, van Domburg PH, et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome. Brain 2001;124:1426\u201337.","DOI":"10.1093\/brain\/124.7.1426"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_011_w2aab3b7c37b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"van Domburg PH, Willemsen MA, Rotteveel JJ, de Jong JG, Thijssen HO, Heerschap A, et al. Sjogren-Larsson syndrome: clinical and MRI\/MRS findings in FALDH-deficient patients. Neurology 1999;52:1345\u201352.","DOI":"10.1212\/WNL.52.7.1345"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_012_w2aab3b7c37b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Willemsen MA, Rotteveel JJ, van Domburg PH, Gabreels FJ, Mayatepek E, Sengers RC. Preterm birth in Sjogren-Larsson syndrome. Neuropediatrics 1999;30:325\u20137.","DOI":"10.1055\/s-2007-973513"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_013_w2aab3b7c37b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Fuijkschot J, Theelen T, Seyger MM, van der Graaf M, de Groot IJ, Wevers RA, et al. Sjogren-Larsson syndrome in clinical practice. J Inherit Metab Dis. 2012;35:955\u201362.","DOI":"10.1007\/s10545-012-9518-6"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_014_w2aab3b7c37b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Willemsen MA, Rotteveel JJ, de Jong JG, Wanders RJ, IJlst L, Hoffmann GF, et al. Defective metabolism of leukotriene B4 in the Sjogren-Larsson syndrome. J Neurol Sci. 2001;183:61\u20137.","DOI":"10.1016\/S0022-510X(00)00474-3"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_015_w2aab3b7c37b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Willemsen MA, de Jong JG, van Domburg PH, Rotteveel JJ, Wanders RJ, Mayatepek E. Defective inactivation of leukotriene B4 in patients with Sjogren-Larsson syndrome. J Pediatr. 2000;136:258\u201360.","DOI":"10.1016\/S0022-3476(00)70113-2"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_016_w2aab3b7c37b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Fuijkschot J, Seyger MM, Bastiaans DE, Wevers RA, Roeleveld N, Willemsen MA. Zileuton for pruritus in Sjogren-Larsson syndrome: a randomized double-blind placebo-controlled crossover trial. Acta Derm Venereol. 2016;96:255\u20136.","DOI":"10.2340\/00015555-2195"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_017_w2aab3b7c37b1b6b1ab2b1c17Aa","unstructured":"CBS. Perinatale en zuigelingensterfte; zwangerschapsduur en geslacht CBS Statline. 2013."},{"key":"2025021114263399713_j_jpm-2017-0187_ref_018_w2aab3b7c37b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Galoin-Bertail C, Ogier de Baulny H, Wanders R, Schiff M, Bellavoine V, Mlika A, et al. [Sjogren-Larsson syndrome: 2 case reports]. Arch Pediatr. 2012;19:135\u201341.","DOI":"10.1016\/j.arcped.2011.11.004"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_019_w2aab3b7c37b1b6b1ab2b1c19Aa","unstructured":"Yis U, Terrinoni A. Sjogren-Larsson syndrome: report of monozygote twins and a case with a novel mutation. Turk J Pediatr. 2012;54:64\u20136."},{"key":"2025021114263399713_j_jpm-2017-0187_ref_020_w2aab3b7c37b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Tanteles GA, Nicolaou M, Patsia N, Delikurt-Tuncalp T, Spanou-Aristidou E, Leonidou E, et al. A rare cause of pruritic ichthyosis: Sjogren-Larsson syndrome in the first reported patients of Cypriot descent. Eur J Dermatol. 2015;25:495\u20136.","DOI":"10.1684\/ejd.2015.2615"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_021_w2aab3b7c37b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Incecik F, Herguner OM, Rizzo WB, Altunbasak S. A Turkish family with Sjogren-Larsson syndrome caused by a novel ALDH3A2 mutation. Ann Indian Acad Neurol. 2013;16:425\u20137.","DOI":"10.4103\/0972-2327.116927"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_022_w2aab3b7c37b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Takeichi T, Sugiura K, Arai H, Ishii K, Kono M, Akiyama M. Sporadic VACTERL association in a Japanese family with Sjogren-Larsson syndrome. Acta Derm Venereol. 2013;93:579\u201380.","DOI":"10.2340\/00015555-1526"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_023_w2aab3b7c37b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Davis K, Holden KR, S\u2019Aulis D, Amador C, Matheus MG, Rizzo WB. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes. J Child Neurol. 2013;28:1259\u201365.","DOI":"10.1177\/0883073812460581"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_024_w2aab3b7c37b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Gaboon NE, Jelani M, Almramhi MM, Mohamoud HS, Al-Aama JY. Case of Sjogren-Larsson syndrome with a large deletion in the ALDH3A2 gene confirmed by single nucleotide polymorphism array analysis. J Dermatol. 2015;42:706\u20139.","DOI":"10.1111\/1346-8138.12861"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_025_w2aab3b7c37b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Brandling-Bennett HA, Liang MG. What syndrome is this? Sjogren-Larsson syndrome. Pediatr Dermatol. 2005;22:569\u201371.","DOI":"10.1111\/j.1525-1470.2005.00143.x"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_026_w2aab3b7c37b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Sakai K, Akiyama M, Watanabe T, Sanayama K, Sugita K, Takahashi M, et al. Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjogren-Larsson syndrome. J Invest Dermatol. 2006;126:2545\u20137.","DOI":"10.1038\/sj.jid.5700453"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_027_w2aab3b7c37b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Rafai MA, Boulaajaj FZ, Seito A, Suga Y, Slassi I, Fadel H. [Sjogren-Larsson syndrome: a novel mutation in a Moroccan child]. Arch Pediatr. 2008;15:1648\u201351.","DOI":"10.1016\/j.arcped.2008.07.022"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_028_w2aab3b7c37b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Mohrenschlager M, Rizzo WB, Kraus CS, Limbrock J, Cohen M, Anton-Lamprecht I, et al. [Sjogren-Larsson syndrome]. Hautarzt. 2000;51:250\u20135.","DOI":"10.1007\/s001050051113"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_029_w2aab3b7c37b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Losito L, Gennaro L, De Rinaldis M, Cacudi M, Trabacca A. Sjogren-Larsson syndrome: phenotypic variability in two brothers with a neurocutaneous disorder. Acta Neurol Belg. 2012;112:205\u20138.","DOI":"10.1007\/s13760-012-0035-z"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_030_w2aab3b7c37b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Tachibana Y, Aida N, Enomoto K, Iai M, Kurosawa K. A case of Sjogren-Larsson syndrome with minimal MR imaging findings facilitated by proton spectroscopy. Pediatr Radiol. 2012;42:380\u20132.","DOI":"10.1007\/s00247-011-2156-6"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_031_w2aab3b7c37b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Nagappa M, Bindu PS, Chiplunkar S, Gupta N, Sinha S, Mathuranath PS, et al. Child neurology: Sjogren-Larsson syndrome. Neurology. 2017;88:e1\u2013e4.","DOI":"10.1212\/WNL.0000000000003456"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_032_w2aab3b7c37b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Anum EA, Hill LD, Pandya A, Strauss JF, 3rd. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta 2009;30:207\u201315.","DOI":"10.1016\/j.placenta.2008.12.007"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_033_w2aab3b7c37b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Lind J, Wallenburg HC. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand. 2002;81:293\u2013300.","DOI":"10.1080\/j.1600-0412.2002.810403.x"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_034_w2aab3b7c37b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Volkov N, Nisenblat V, Ohel G, Gonen R. Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv. 2007;62:51\u20137.","DOI":"10.1097\/01.ogx.0000251027.32142.63"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_035_w2aab3b7c37b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Bygum A, Westermark P, Brandrup F. Ichthyosis prematurity syndrome: a well-defined congenital ichthyosis subtype. J Am Acad Dermatol. 2008;59:S71\u20134.","DOI":"10.1016\/j.jaad.2008.06.014"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_036_w2aab3b7c37b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Klar J, Schweiger M, Zimmerman R, Zechner R, Li H, T\u00f6rm\u00e4 H, et al. Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet. 2009;85:248\u201353.","DOI":"10.1016\/j.ajhg.2009.06.021"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_037_w2aab3b7c37b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Caridi G, Gulec EY, Campagnoli M, Lugani F, Onal H, Kilic D, et al. A nucleotide deletion and frame-shift cause analbuminemia in a Turkish family. Biochem Med (Zagreb). 2016;26:264\u201371.","DOI":"10.11613\/BM.2016.031"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_038_w2aab3b7c37b1b6b1ab2b1c38Aa","unstructured":"Toye JM, Lemire EG, Baerg KL. Perinatal and childhood morbidity and mortality in congenital analbuminemia. Paediatr Child Health. 2012;17:e20\u20133."},{"key":"2025021114263399713_j_jpm-2017-0187_ref_039_w2aab3b7c37b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Lopez Bernal A, Hansell DJ, Khong TY, Keeling JW, Turnbull AC. Placental leukotriene B4 release in early pregnancy and in term and preterm labour. Early Hum Dev. 1990;23:93\u20139.","DOI":"10.1016\/0378-3782(90)90132-3"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_040_w2aab3b7c37b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Jian F, Ma Y, Liu Z, Wang L, Zhang Y. The change of LTB4 and 5-LO during pregnancy. Arch Gynecol Obstet. 2013;288:769\u201373.","DOI":"10.1007\/s00404-013-2823-y"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_041_w2aab3b7c37b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Lopez Bernal A, Hansell DJ, Canete Soler R, Keeling JW, Turnbull AC. Prostaglandins, chorioamnionitis and preterm labour. Br J Obstet Gynaecol. 1987;94:1156\u20138.","DOI":"10.1111\/j.1471-0528.1987.tb02315.x"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_042_w2aab3b7c37b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Maddipati KR, Romero R, Chaiworapongsa T, Chaemsaithong P, Zhou SL, Xu Z, et al. Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4. FASEB J. 2016;30:3296\u2013307.","DOI":"10.1096\/fj.201600583R"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_043_w2aab3b7c37b1b6b1ab2b1c43Aa","unstructured":"Romero R, Emamian M, Wan M, Grzyboski C, Hobbins JC, Mitchell MD. Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition. Obstet Gynecol. 1987;70:849\u201351."},{"key":"2025021114263399713_j_jpm-2017-0187_ref_044_w2aab3b7c37b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"Romero R, Quintero R, Emamian M, Wan M, Grzyboski C, Hobbins JC, et al. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol. 1987;157:1454\u201360.","DOI":"10.1016\/S0002-9378(87)80243-0"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_045_w2aab3b7c37b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Romero R, Wu YK, Mazor M, Oyarzun E, Hobbins JC, Mitchell MD. Amniotic fluid arachidonate lipoxygenase metabolites in preterm labor. Prostaglandins Leukot Essent Fatty Acids. 1989;36:69\u201375.","DOI":"10.1016\/0952-3278(89)90020-3"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_046_w2aab3b7c37b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Carraher R, Hahn DW, Ritchie DM, McGuire JL. Involvement of lipoxygenase products in myometrial contractions. Prostaglandins 1983;26:23\u201332.","DOI":"10.1016\/0090-6980(83)90071-0"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_047_w2aab3b7c37b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"Sakata M, Sado T, Kitanaka T, Naruse K, Noguchi T, Yoshida S, et al. Iron-dependent oxidative stress as a pathogenesis for preterm birth. Obstet Gynecol Surv. 2008;63:651\u201360.","DOI":"10.1097\/OGX.0b013e318181a79f"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_048_w2aab3b7c37b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"York TP, Eaves LJ, Lichtenstein P, Neale MC, Svensson A, Latendresse S, et al. Fetal and maternal genes\u2019 influence on gestational age in a quantitative genetic analysis of 244,000 Swedish births. Am J Epidemiol. 2013;178:543\u201350.","DOI":"10.1093\/aje\/kwt005"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_049_w2aab3b7c37b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med. 1998;338:663\u201370.","DOI":"10.1056\/NEJM199803053381006"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_050_w2aab3b7c37b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101\u201316.","DOI":"10.1136\/jmg.16.2.101"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_051_w2aab3b7c37b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"Moulson CL, Go G, Gardner JM, van der Wal AC, Smitt JH, van Hagen JM, et al. Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol. 2005;125:913\u20139.","DOI":"10.1111\/j.0022-202X.2005.23846.x"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_052_w2aab3b7c37b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Mau U, Kendziorra H, Kaiser P, Enders H. Restrictive dermopathy: report and review. Am J Med Genet. 1997;71:179\u201385.","DOI":"10.1002\/(SICI)1096-8628(19970808)71:2<179::AID-AJMG11>3.0.CO;2-B"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_053_w2aab3b7c37b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"Corriveau S, Rousseau E, Blouin S, Pasquier JC. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility. Eur J Obstet Gynecol Reprod Biol. 2014;177:77\u201383.","DOI":"10.1016\/j.ejogrb.2014.02.042"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_054_w2aab3b7c37b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"Chen B, Ji X, Zhang L, Hou Z, Li C, Tong Y. Fish oil supplementation improves pregnancy outcomes and size of the newborn: a meta-analysis of 21 randomized controlled trials. J Matern Fetal Neonatal Med. 2016;29:2017\u201327.","DOI":"10.3109\/14767058.2015.1072163"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_055_w2aab3b7c37b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47:147\u201355.","DOI":"10.1016\/j.plipres.2007.12.004"},{"key":"2025021114263399713_j_jpm-2017-0187_ref_056_w2aab3b7c37b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Willemsen MA, Rotteveel JJ, Steijlen PM, Heerschap A, Mayatepek E. 5-Lipoxygenase inhibition: a new treatment strategy for Sjogren-Larsson syndrome. Neuropediatrics. 2000;31:1\u20133.","DOI":"10.1055\/s-2000-15288"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpme.2018.46.issue-5\/jpm-2017-0187\/jpm-2017-0187.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0187\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0187\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T14:26:47Z","timestamp":1739284007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2017-0187\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,15]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,15]]},"published-print":{"date-parts":[[2018,7,26]]}},"alternative-id":["10.1515\/jpm-2017-0187"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2017-0187","relation":{},"ISSN":["1619-3997","0300-5577"],"issn-type":[{"value":"1619-3997","type":"electronic"},{"value":"0300-5577","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,15]]}}}